Clinical ResearchBiomarkersThe Predictive Ability of Pre-Operative B-Type Natriuretic Peptide in Vascular Patients for Major Adverse Cardiac Events: An Individual Patient Data Meta-Analysis
Key Words
Abbreviations and Acronyms
Cited by (0)
Dr. Rodseth is supported by a CIHR Scholarship (the Canada-HOPE Scholarship). Dr. Lurati Buse is supported by a scholarship by the Swiss National Science Foundation. Dr. Bolliger has received an unrestricted research grant from CSL Behring (Berne, Switzerland). Dr. Mahla has received N-terminal pro-B-type natriuretic peptide kits from Roche Diagnostics GmbH (Mannheim, Germany), study grants from Novo Nordisk Pharma GmbH (Vienna, Austria) and CSL Behring Biotherapies for Life (Vienna, Austria), and speaker honoraria and consulting fees from CSL Behring Biotherapies for Life. Dr. Biccard is supported by a self-initiated research grant from the Medical Research Council. All other authors have reported that they have no relationships to disclose.